
Shares of surgical equipment maker Teleflex TFX.N fall 11.6% to $157 premarket
Company forecast 2025 adj profit per share to be between $13.95 and $14.35; analysts had forecast $15.23 per share, according to data compiled by LSEG
Posts Q4 profit of $3.89 per share vs estimate of $3.86 per share
Separately, co plans to split into two cos, with urology, acute care and contract manufacturing businesses to be spun off into separate unit
Co to buy Germany-based Biotronik's blood vessel device unit for about 760 million euros ($796.3 million) in cash to boost Teleflex's core business
TFX CFO Thomas E. Powell has decided to retire effective April 1
TFX has fallen 22% in the last 12 months